NM-702 Completed Phase 2 Trials for Intermittent Claudication / Peripheral Vascular Disease Patient Treatment

IndicationsStatusPurposePhase
CompletedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT00102050Efficacy and Safety of NM-702 Tablets for the Treatment of Intermittent Claudication